Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


Last --
Change Today 0.00 / 0.00%
Volume 0.0
2267 On Other Exchanges
Symbol
Exchange
2267 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

yakult honsha co ltd (2267) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for YAKULT HONSHA CO LTD (2267)

Related News

No related news articles were found.

yakult honsha co ltd (2267) Related Businessweek News

View More BusinessWeek News

yakult honsha co ltd (2267) Details

Yakult Honsha Co., Ltd. manufactures and sells food and beverage products. It operates through Food and Beverages (Japan), Food and Beverages (The Americas), Food and Beverages (Asia and Oceania), Food and Beverages (Europe), Pharmaceuticals, and Others segments. The company offers fermented milk drinks, juices, noodles, etc. through its home delivery and retail store channels. It also provides pharmaceutical products, such as Elplat, a cancer chemotherapeutic agent for the treatment of colorectal cancer; Levofolinate Yakult, an activated folic acid drug; Gemcitabine Yakult, an antineoplastic antimetabolite; Imatinib yakult, a generic antineoplastic drug; Zoledronic acid Yakult, a generic drug for bone lesions; and Campto, a cancer chemotherapeutic agent. In addition, the company is developing Elplat for gastric cancer. Further, it offers cosmetics and skin care products under the Parabio, Revecy, and Revecy White brand names; Bellefin moisture essence, a moisturizing serum; Yakult sunscreen S.E. series; Crystance white repair essence, a whitening serum; and Yakult treatment repair mask, a face mask, as well as operates and manages the Tokyo Yakult Swallows, a professional baseball team. The company was founded in 1935 and is headquartered in Tokyo, Japan.

20,492 Employees
Last Reported Date: 06/25/15
Founded in 1935

yakult honsha co ltd (2267) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: ¥150.0M
Compensation as of Fiscal Year 2015.

yakult honsha co ltd (2267) Key Developments

Yakult Honsha Co. Ltd. Reports Consolidated and Non-Consolidated Earnings Results for the Nine Months Ended December 31, 2015

Yakult Honsha Co. Ltd. reported consolidated and non-consolidated earnings results for the nine months ended December 31, 2015. For the period, on consolidated basis, the company reported net sales of JPY 299,826 million compared to JPY 279,907 million a year ago. Operating profit was JPY 36,101 million compared to operating profit of JPY 29,488 million a year ago. Ordinary income was JPY 45,838 million compared to ordinary income of JPY 36,628 million a year ago. Profit attributable to owners of the parent was JPY 28,315 million compared to profit attributable to owners of the parent of JPY 21,553 million a year ago. Profit before income taxes and minority interest was JPY 45,635 million compared to JPY 36,427 million a year ago. For the period, on non-consolidated basis, the company reported net sales of JPY 137,640 million compared to JPY 136,656 million a year ago. Operating profit was JPY 4,152 million compared to operating profit of JPY 4,502 million a year ago. Ordinary income was JPY 10,366 million compared to ordinary income of JPY 9,307 million a year ago. Profit attributable to owners of the parent was JPY 8,307 million compared to profit attributable to owners of the parent of JPY 7,344 million a year ago.

Yakult Honsha Co. Ltd. to Report Q3, 2016 Results on Jan 29, 2016

Yakult Honsha Co. Ltd. announced that they will report Q3, 2016 results on Jan 29, 2016

Yakult Honsha Co. Ltd., Q3 2016 Earnings Call, Jan 29, 2016

Yakult Honsha Co. Ltd., Q3 2016 Earnings Call, Jan 29, 2016

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
2267:JP ¥5,540.00 JPY +110.00

2267 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott India Ltd 4,980 INR -5.75
BioGaia AB kr230.00 SEK -5.00
Biostime International Holdings Ltd $21.65 HKD -1.25
Mead Johnson Nutrition Co $71.94 USD +2.30
View Industry Companies
 

Industry Analysis

2267

Industry Average

Valuation 2267 Industry Range
Price/Earnings 29.0x
Price/Sales 2.4x
Price/Book 2.7x
Price/Cash Flow 29.0x
TEV/Sales 1.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact YAKULT HONSHA CO LTD, please visit www.yakult.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.